Pneuma’s patented technology delivers a dramatic improvement in the level of droplet size control, a highly accurate metered dose, breath actuation, and a digital data capture of a variety of technical and user compliance information to further aid healthcare professionals and users. The technology does not use heat energy, avoiding undesirable thermal decomposition of the drug, or creation of toxic degradation compounds. The droplet generation method transmits minimal energy to the drug making the platform compatible with the latest biologic drugs and other fragile compounds. The efficient design is pocket sized, durable and easy to use.

Pneuma’s digital/connected design utilizes sensors to collect data on device performance, patient compliance, patient health parameters and other information of interest. This data can be transmitted to healthcare providers to assess progress and adjust treatment. The data can also be used to provide user feedback, to encourage compliance and enable digital re-order of medication to maintain the continuity of care.

Pneuma’s integration of novel droplet technology, digital control and an intuitive connected platform enables better drug delivery, more informed healthcare providers, better patient compliance creating better health outcomes.

Pneuma has extensive intellectual property with 4 granted patents, 43 pending applications and 10 provisional patent families. The intellectual property strategy covers the device, methods of treatment and methods of droplet generation.